goralatide has been researched along with Hypertension in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Bernstein, EA; Bernstein, KE; Cao, D; Giani, JF; Gonzalez-Villalobos, RA; Khan, Z; Okwan-Duodu, D; Shen, JZY; Veiras, LC | 1 |
| Carretero, OA; Kumar, N; Liao, TD; Maheshwari, M; Monu, SR; Peterson, EL; Romero, CA | 1 |
| Kumar, N; Yin, C | 1 |
| Carretero, OA; Dai, X; González, GE; Leung, P; Liao, TD; Liu, Y; Nakagawa, P; Rhaleb, NE; Yang, XP | 1 |
| Carretero, OA; D'Ambrosio, M; Janic, B; Liao, TD; Nakagawa, P; Peterson, EL; Rhaleb, NE; Worou, ME | 1 |
| Basha, H; Carretero, OA; Janic, B; Liao, TD; Masjoan-Juncos, JX; Nakagawa, P; Peterson, EL; Romero, CA; Worou, ME | 1 |
| Carretero, OA; D'Ambrosio, MA; Liao, TD; Lin, CX; Rhaleb, NE; Yang, XP | 1 |
| Hino, T; Ikemura, A; Inoue, K; Oka, H; Tsuruta, Y; Tsutsumiuchi, K; Watanabe, K | 1 |
| Carretero, OA; Cingolani, OH; Liu, YH; Rhaleb, NE; Villanueva, M; Yang, XP | 1 |
| Brigstock, DR; Carretero, OA; Cavasin, MA; Peng, H; Rasoul, S; Rhaleb, NE; Sanchez-Mendoza, A; Zhuo, J | 1 |
| Azizi, M; Chatellier, G; Lièvre, M; Marre, M; Ménard, J; Peyrard, S | 1 |
| Carretero, OA; Liao, TD; Peng, H; Peterson, EL; Rhaleb, NE | 1 |
| Carretero, OA; Harding, P; Peng, H; Pokharel, S; Rasoul, S; Rhaleb, NE; Sharma, U | 1 |
| Aldigier, JC; Le Meur, Y; Praloran, V | 1 |
| Carretero, OA; Harding, P; LaPointe, MC; Peng, H; Rhaleb, NE; Tayeh, M | 1 |
| Azizi, M; Ezan, E; Junot, C; Ménard, J | 1 |
2 review(s) available for goralatide and Hypertension
| Article | Year |
|---|---|
Novel roles of the renal angiotensin-converting enzyme.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Bradykinin; Diabetic Nephropathies; Gene Expression Regulation; Humans; Hypertension; Kidney; Mice; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction; Water-Electrolyte Balance | 2021 |
The anti-inflammatory peptide Ac-SDKP: Synthesis, role in ACE inhibition, and its therapeutic potential in hypertension and cardiovascular diseases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Humans; Hydrolysis; Hypertension; Oligopeptides; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction | 2018 |
1 trial(s) available for goralatide and Hypertension
| Article | Year |
|---|---|
Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Guideline Adherence; Humans; Hypertension; Male; Middle Aged; Oligopeptides; Patient Compliance; Physicians; Placebos; Proteinuria | 2006 |
13 other study(ies) available for goralatide and Hypertension
| Article | Year |
|---|---|
Renal Protective Effects of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) in Obese Rats on a High-Salt Diet.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Fibrosis; Glomerulonephritis; Hypertension; Kidney; Macrophages; Male; Obesity; Oligopeptides; Rats, Zucker; Sodium Chloride, Dietary | 2018 |
N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Body Weight; Cardiomegaly; CD4-Positive T-Lymphocytes; Collagen; Extracellular Matrix; Hypertension; Inflammation; Lung; Male; NF-kappa B; Oligopeptides; Organ Size; Protein-Lysine 6-Oxidase; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling | 2014 |
Renal protective effect of N-acetyl-seryl-aspartyl-lysyl-proline in dahl salt-sensitive rats.
Topics: Animals; Blood Pressure; Disease Models, Animal; Glomerular Filtration Rate; Growth Inhibitors; Hypertension; Kidney; Male; Oligopeptides; Rats; Rats, Inbred Dahl | 2015 |
Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus.
Topics: Albuminuria; Animals; Blood Pressure; Female; Fibrosis; Hypertension; Kidney; Kidney Diseases; Lupus Erythematosus, Systemic; Mice; Oligopeptides; Survival Analysis; T-Lymphocytes | 2017 |
Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Aorta; Collagen; Elastin; Enzyme Activation; Fibrosis; Heart Diseases; Hypertension; Immunohistochemistry; Intercellular Adhesion Molecule-1; Lipid Metabolism; Male; Neutrophil Infiltration; Oligopeptides; Oxidation-Reduction; Phosphorylation; Protein Kinase C; Rats; Rats, Sprague-Dawley; Smad2 Protein; Transforming Growth Factor beta1; Vasoconstrictor Agents | 2008 |
Quantification of N-acetyl-seryl-aspartyl-lysyl-proline in hemodialysis patients administered angiotensin-converting enzyme inhibitors by stable isotope dilution liquid chromatography-tandem mass spectrometry.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Carbon Isotopes; Chromatography, High Pressure Liquid; Deuterium; Drug Monitoring; Female; Humans; Hypertension; Indicator Dilution Techniques; Male; Middle Aged; Nitrogen Isotopes; Oligopeptides; Peptide Fragments; Renal Dialysis; Renal Insufficiency; Solid Phase Extraction; Tandem Mass Spectrometry; Thymosin | 2011 |
Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats.
Topics: Animals; Capillaries; Cell Size; Collagen; Diastole; Fibrosis; Heart Ventricles; Hydroxyproline; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Oligopeptides; Pressure; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Systole | 2004 |
Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cell Division; Collagen; Connective Tissue Growth Factor; Drug Therapy, Combination; Fibrosis; Growth Inhibitors; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Macrophages; Male; Mast Cells; Monocytes; Myocardium; Myocytes, Cardiac; Oligopeptides; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2004 |
Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and anti-inflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Captopril; Disease Models, Animal; Enzyme Activation; Fibrosis; Heart; Hypertension; Inflammation; Kidney; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oligopeptides; Rats | 2007 |
Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Azo Compounds; Blotting, Western; Cardiomegaly; Cell Separation; Collagen; Fibrosis; Galectin 3; Heart Rate; Hypertension; In Vitro Techniques; Inflammation; Kidney; Male; Mice; Mice, Inbred C57BL; Myocardium; Neutrophil Infiltration; Oligopeptides; Stem Cells; Tumor Necrosis Factor-alpha | 2008 |
Is plasma Ac-SDKP level a reliable marker of chronic angiotensin-converting enzyme inhibition in hypertensive patients?
Topics: Biomarkers; Humans; Hypertension; Oligopeptides; Peptidyl-Dipeptidase A | 1998 |
Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cells, Cultured; Collagen; DNA; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardium; Oligopeptides; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System | 2001 |
Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hydrolysis; Hypertension; Mice; Oligopeptides; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Rats; Structure-Activity Relationship; Substrate Specificity | 2001 |